Who Supplies Ondansetron? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ondansetron exports, with 537+ registered manufacturers shipping to buyers across 157+ countries — yet a handful of companies dominate the shipments. AUROBINDO PHARMA LTD holds the largest share at 9.9% (export value: $12.0M). Close behind, GLENMARK PHARMACEUTICALS LIMITED (7.2%, $8.7M). AUROBINDO PHARMA LIMITED (6.3%, $7.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ondansetron? Top Manufacturers & Their Buyers
Flow of Ondansetron from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ondansetron Supplier Network — Key Market Intelligence
The Ondansetron export market from India is led by AUROBINDO PHARMA LTD, which alone commands a 9.9% share, shipping $12.0M worth of product across 741 shipments. The second-largest exporter, GLENMARK PHARMACEUTICALS LIMITED, contributes $8.7M (7.2%) to the overall market. Combined, the top two suppliers alone account for 17.1% of all Ondansetron exports, indicating a relatively concentrated supply base.
Across all 537 tracked manufacturers, the total Ondansetron export value stands at $121.0M from 8.5K shipments. The market average shipment value is $14.3K. The single largest buyer relationship in terms of trade value is GLENMARK PHARMACEUTICALS INC USA, receiving $3.6M worth of product.
The combined buyer network spans 16 named purchasing companies, including AUROLOGISTICS LLC (AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC. ,, NORTHSTAR DISTRIBUTION CENTER 8912, AUROLOGISTICS LLC AUROBINDO PHARM, GLENMARK PHARMACEUTICALS INC USA and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the first-largest Ondansetron exporter from India, with a market share of 9.9% and a total export value of $12.0M across 741 shipments. Their average shipment value of $16.2K is above the market average of $14.3K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $2.9M across 181 shipments (24.4% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $2.9M across 179 shipments (24.2% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $2.9M across 178 shipments (24.1% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $2.0M across 125 shipments (16.8% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $1.3M across 78 shipments (10.5% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $16.2K is 13% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.
2GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the second-largest Ondansetron exporter from India, with a market share of 7.2% and a total export value of $8.7M across 635 shipments. Their average shipment value of $13.6K is below the market average of $14.3K, reflecting a high-volume, competitive pricing strategy.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• GLENMARK PHARMACEUTICALS INC USA — $3.6M across 266 shipments (41.9% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC USA — $3.2M across 235 shipments (36.9% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES DBA AME — $714.7K across 52 shipments (8.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC USA — $628.5K across 46 shipments (7.3% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES DBA AME — $493.8K across 36 shipments (5.7% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (635 shipments) at a per-shipment value of $13.6K, indicating a broad distribution network with many smaller, regular orders.
3AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the third-largest Ondansetron exporter from India, with a market share of 6.3% and a total export value of $7.6M across 244 shipments. Their average shipment value of $31.1K is above the market average of $14.3K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $2.7M across 86 shipments (35.3% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $2.0M across 66 shipments (27.0% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.1M across 36 shipments (14.9% of this supplier's total exports)
• AUROLOGISTICS LLC — $1.0M across 33 shipments (13.4% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $713.0K across 23 shipments (9.4% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $31.1K is 118% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.
4BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the fourth-largest Ondansetron exporter from India, with a market share of 4.5% and a total export value of $5.5M across 272 shipments. Their average shipment value of $20.0K is above the market average of $14.3K, suggesting premium or bulk contract pricing.
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BAXTER DISTRIBUTION CENTRE EUROPE S — $2.3M across 116 shipments (42.6% of this supplier's total exports)
• BAXTER HEALTHCARE CORPORATION — $1.0M across 50 shipments (18.4% of this supplier's total exports)
• LABORATORIOS BAXTER — $928.9K across 46 shipments (17.0% of this supplier's total exports)
• ADVANCED TECHNOLOGY — $659.6K across 33 shipments (12.1% of this supplier's total exports)
• LABORATORIOS BAXTER — $539.7K across 27 shipments (9.9% of this supplier's total exports)
Key Insight: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $20.0K is 40% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.
5GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the fifth-largest Ondansetron exporter from India, with a market share of 3.0% and a total export value of $3.6M across 101 shipments. Their average shipment value of $35.5K is above the market average of $14.3K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AVET PHARMACEUTICALS INC — $1.4M across 39 shipments (38.1% of this supplier's total exports)
• AVET PHARMACEUTICALS INC — $1.4M across 38 shipments (37.6% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES — $869.8K across 24 shipments (24.2% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $35.5K is 149% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.
6DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the fifth-largest Ondansetron exporter from India, with a market share of 1.6% and a total export value of $2.0M across 213 shipments. Their average shipment value of $9.2K is below the market average of $14.3K, reflecting a high-volume, competitive pricing strategy.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR.REDDY'S LABORATOR — $616.2K across 67 shipments (31.3% of this supplier's total exports)
• DR. REDDYS LABORATOR — $442.5K across 48 shipments (22.5% of this supplier's total exports)
• DR.REDDY'S LABORATOR — $374.4K across 41 shipments (19.0% of this supplier's total exports)
• DR. REDDYS LABORATOR — $345.0K across 37 shipments (17.5% of this supplier's total exports)
• PREET RATTAN — $190.3K across 21 shipments (9.7% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (213 shipments) at a per-shipment value of $9.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Ondansetron Flows
Once Ondansetron leaves the manufacturing plants of companies like AUROBINDO PHARMA LTD and GLENMARK PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $121.0M. United States absorbs the largest share at 58.8% ($71.2M), followed by Australia (6.0%) and South Africa (5.7%).
In United States — the top destination — named importers include GLENMARK PHARMACEUTICALS INC., USA, AUROLOGISTICS LLC, (AUROBINDO PHARM, AVET PHARMACEUTICALS INC.
This geographic spread reflects Ondansetron's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ondansetron Go? Top Importing Countries & Their Buyers
Trade flow of Ondansetron exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Ondansetron imports from India, with a total trade value of $71.2M across 1,492 shipments — representing a 58.8% share of all Ondansetron exports. The average shipment value of $47.7K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 16 tracked buyers.
Named Ondansetron importers in United States: GLENMARK PHARMACEUTICALS INC., USA is the largest buyer, accounting for 10.7% ($7.6M) of this market's total imports.
• GLENMARK PHARMACEUTICALS INC., USA — $7.6M (10.7% of United States's total)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $7.0M (9.9% of United States's total)
• AVET PHARMACEUTICALS INC — $5.8M (8.2% of United States's total)
Key Insight: United States's per-shipment average of $47.7K (234% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Ondansetron imports from India.
2Australia
Australia ranks as the second-largest destination for Ondansetron imports from India, with a total trade value of $7.3M across 0 shipments — representing a 6.0% share of all Ondansetron exports. The average shipment value of $7.3M is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Australia's per-shipment average of $7.3M (50935% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Ondansetron imports from India.
3South Africa
South Africa ranks as the third-largest destination for Ondansetron imports from India, with a total trade value of $7.0M across 9 shipments — representing a 5.7% share of all Ondansetron exports. The average shipment value of $772.5K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ondansetron importers in South Africa: RANBAXY PHARMACEUTICALS PTY LTD is the largest buyer, accounting for 29.4% ($2.0M) of this market's total imports.
• RANBAXY PHARMACEUTICALS PTY LTD — $2.0M (29.4% of South Africa's total)
• RANBAXY PHARMACEUTICALS PTY LTD., — $1.3M (19.2% of South Africa's total)
Key Insight: South Africa's per-shipment average of $772.5K (5305% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Ondansetron imports from India.
4Canada
Canada ranks as the fourth-largest destination for Ondansetron imports from India, with a total trade value of $3.8M across 17 shipments — representing a 3.1% share of all Ondansetron exports. The average shipment value of $222.2K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ondansetron importers in Canada: STERIMAX INC is the largest buyer, accounting for 30.1% ($1.1M) of this market's total imports.
• STERIMAX INC — $1.1M (30.1% of Canada's total)
Key Insight: Canada's per-shipment average of $222.2K (1454% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Ondansetron imports from India.
5Belgium
Belgium ranks as the fifth-largest destination for Ondansetron imports from India, with a total trade value of $2.8M across 80 shipments — representing a 2.3% share of all Ondansetron exports. The average shipment value of $34.9K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ondansetron importers in Belgium: BAXTER DISTRIBUTION CENTRE EUROPE S is the largest buyer, accounting for 96.9% ($2.7M) of this market's total imports.
• BAXTER DISTRIBUTION CENTRE EUROPE S — $2.7M (96.9% of Belgium's total)
Key Insight: Belgium's per-shipment average of $34.9K (144% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Ondansetron imports from India.
People Also Ask — Ondansetron Supplier & Trade Network
Who are the top suppliers of Ondansetron from India?+
Which companies buy Ondansetron from Indian manufacturers?+
Where does Ondansetron exported from India go?+
What is the market share of the top Ondansetron supplier from India?+
What is the average shipment value for Ondansetron exports from India?+
Is Ondansetron manufactured in India and exported globally?+
Which country imports the most Ondansetron from India?+
Who are the buyers of Ondansetron in Australia?+
How concentrated is the Ondansetron supplier market in India?+
How do I find verified buyers for Ondansetron in specific countries?+
Ondansetron Trade Network — Key Takeaways
- 1AUROBINDO PHARMA LTD is India's dominant Ondansetron exporter with a 9.9% market share and $12.0M in total exports — making it the single most important sourcing entity in this market.
- 2The top 537 suppliers collectively account for 32.4% of all tracked Ondansetron exports, with a combined trade value of $121.0M.
- 3United States is the largest destination market, absorbing 58.8% of India's Ondansetron exports ($71.2M). Australia (6.0%) and South Africa (5.7%) follow.
- 4With 8.5K total shipments averaging $14.3K each, the Ondansetron export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AUROLOGISTICS LLC (AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC. ,, GLENMARK PHARMACEUTICALS INC USA, GLENMARK PHARMACEUTICALS INC USA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 157 countries
Network value: $121.0M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ondansetron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ondansetron.
- 2.Flow Mapping: 537 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 8,469 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 157 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,469 Verified Shipments
537 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists